| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM199008163230705 |
| P698 | PubMed publication ID | 2095753 |
| P2093 | author name string | Yamada M | |
| Lange B | |||
| Rovera G | |||
| Womer RB | |||
| Wasserman R | |||
| Reichard BA | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 448-455 | |
| P577 | publication date | 1990-08-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment | |
| P478 | volume | 323 |
| Q40884711 | Advances in the diagnosis of acute leukemia. |
| Q35831265 | Application of a multiprobe RNase protection assay and junctional sequences to define V beta gene diversity in Sezary syndrome |
| Q40431716 | Applications and Limitations of Polymerase Chain Reaction Amplification |
| Q35832999 | Assessment of clonality in lymphoid proliferations |
| Q73046027 | B-cell gene rearrangement in benign and malignant lymphoid proliferations of mucosa-associated lymphoid tissue and lymph nodes |
| Q40558263 | Bone marrow transplantation for acute lymphoblastic leukaemia |
| Q24336990 | CRIF1 interacting with CDK2 regulates bone marrow microenvironment-induced G0/G1 arrest of leukemia cells |
| Q35598751 | Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells |
| Q40493980 | Clinical Significance of Minimal Residual Disease in Leukemia Detected by Polymerase Chain Reaction: Is Molecular Remission a Milestone for Achieving a Cure? |
| Q71784751 | Detection of Minimal Residual Disease |
| Q35833032 | Detection of clonal immunoglobulin gene rearrangements by polymerase chain reaction amplification and single-strand conformational polymorphism analysis |
| Q67555858 | Detection of immunoglobulin gene rearrangement in B-cell lymphomas by polymerase chain reaction gene amplification |
| Q34305209 | Detection of minimal residual disease |
| Q73170787 | Detection of minimal residual disease |
| Q58415188 | Elimination of B-lineage leukemia and lymphoma cells from bone marrow grafts using anti-B4-blocked-ricin immunotoxin |
| Q53801644 | Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease. |
| Q40558199 | Genetic changes: relevance for diagnosis and detection of minimal residual disease in acute lymphoblastic leukaemia |
| Q34261353 | Immunoglobulin variable region structure and B-cell malignancies |
| Q58961531 | Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia |
| Q68323379 | Maintenance chemotherapy and cure of childhood acute lymphoblastic leukaemia |
| Q45055515 | Malignant cell detection in Burkitt's lymphoma using third-complementarity-determining region (CDRIII), clone-specific probe developed by sequencing DNA from stored slides |
| Q37307811 | Minimal Residual Disease Detection and Evolved IGH Clones Analysis in Acute B Lymphoblastic Leukemia Using IGH Deep Sequencing. |
| Q38452047 | Minimal Residual Disease Monitoring in Adult ALL to Determine Therapy |
| Q58855561 | Minimal residual disease in Brazilian children with acute lymphoid leukemia: comparison of three detection methods by PCR |
| Q67900966 | Minimal residual disease in acute leukaemia |
| Q72664667 | Minimal residual disease in childhood acute lymphoblastic leukaemia |
| Q52024443 | Modeling minimal residual disease (MRD)-testing. |
| Q35414953 | Molecular biology in medicine |
| Q41252914 | Molecular genetics and lymphoproliferative disorders |
| Q42269589 | Molecular monitoring of low grade non-Hodgkin's lymphoma by gene amplification |
| Q34321881 | Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction |
| Q36960646 | Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study |
| Q73583223 | Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases |
| Q36232084 | Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event |
| Q36292360 | Putative markers for the detection of breast carcinoma cells in blood |
| Q35989461 | Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01. |
| Q40831551 | Role of autologous bone marrow transplantation for patients with acute and chronic leukemias. |
| Q42050130 | Stem cell origins of leukaemia and curability |
| Q97426131 | Stiffness based enrichment of leukemia cells using microfluidics |
| Q40473307 | Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology era |
| Q38341591 | Synthesis of quantitation standards for nested competitive PCR for the determination of minimal residual disease in B-lineage acute lymphoblastic leukaemia |
| Q36362222 | The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell |
| Q34265967 | The clinical pharmacology of 6-mercaptopurine |
| Q40845555 | The clinical significance of detection of residual disease in childhood ALL. |
| Q36334294 | The detection of minimal residual disease in acute lymphoblastic leukaemia |
| Q40462686 | The molecular detection of circulating tumour cells |
| Q37545980 | The molecular genetic analysis of gene rearrangements in acute lymphoblastic leukaemia |
| Q37080873 | The polymerase chain reaction: A new tool for the detection of minimal residual disease in haematological malignancies |
| Q40848677 | The study of minimal residual disease in acute lymphoblastic leukaemia |
| Q40920400 | The use of the polymerase chain reaction to detect minimal residual disease in childhood acute lymphoblastic leukaemia. |
| Q37019276 | Transplantation of Normal and Leukemic Human Bone Marrow into Immune-Deficient Mice: Development of Animal Models for Human Hematopoiesis |
Search more.